RadNet EBITDA 2010-2024 | RDNT

RadNet ebitda from 2010 to 2024. Ebitda can be defined as earnings before interest, taxes, depreciation and amortization.
RadNet Annual EBITDA
(Millions of US $)
2024 $315
2023 $295
2022 $237
2021 $260
2020 $198
2019 $222
2018 $108
2017 $120
2016 $110
2015 $105
2014 $118
2013 $107
2012 $111
2011 $115
2010 $101
2009 $106
RadNet Quarterly EBITDA
(Millions of US $)
2024-12-31 $77
2024-09-30 $86
2024-06-30 $92
2024-03-31 $60
2023-12-31 $72
2023-09-30 $93
2023-06-30 $74
2023-03-31 $55
2022-12-31 $71
2022-09-30 $55
2022-06-30 $67
2022-03-31 $44
2021-12-31 $50
2021-09-30 $78
2021-06-30 $72
2021-03-31 $60
2020-12-31 $63
2020-09-30 $64
2020-06-30 $40
2020-03-31 $31
2019-12-31 $62
2019-09-30 $55
2019-06-30 $60
2019-03-31 $44
2018-12-31 $20
2018-09-30 $35
2018-06-30 $35
2018-03-31 $18
2017-12-31 $36
2017-09-30 $29
2017-06-30 $32
2017-03-31 $24
2016-12-31 $33
2016-09-30 $31
2016-06-30 $25
2016-03-31 $21
2015-12-31 $29
2015-09-30 $33
2015-06-30 $29
2015-03-31 $15
2014-12-31 $30
2014-09-30 $31
2014-06-30 $34
2014-03-31 $23
2013-12-31 $27
2013-09-30 $26
2013-06-30 $30
2013-03-31 $24
2012-12-31 $23
2012-09-30 $29
2012-06-30 $32
2012-03-31 $28
2011-12-31 $32
2011-09-30 $27
2011-06-30 $32
2011-03-31 $24
2010-12-31 $31
2010-09-30 $26
2010-06-30 $26
2010-03-31 $19
2009-12-31 $37
2009-09-30 $23
2009-06-30 $23
2009-03-31 $23
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $4.453B $1.617B
RadNet, Inc., is a national market leader providing high-quality, cost-effective diagnostic imaging services through a network of fully-owned and operated outpatient imaging centers. RadNet offers to its patients and referring physicians the full spectrum of diagnostic imaging exams, including PET/CT, MRI, CT, Nuclear Medicine, Mammography, Ultrasound and X-ray, as well as numerous other procedures. RadNet utilizes best of breed technology to appropriately serve the medical communities in which it operates.
Stock Name Country Market Cap PE Ratio
Fresenius SE (FSNUY) Germany $21.804B 0.00
Quest Diagnostics (DGX) United States $19.317B 19.51
DaVita (DVA) United States $11.363B 14.49
Encompass Health (EHC) United States $9.962B 22.32
Chemed (CHE) United States $8.236B 25.31
Elanco Animal Health (ELAN) United States $5.492B 13.07
Option Care Health (OPCH) United States $5.459B 25.87
Amedisys (AMED) United States $2.998B 21.34
LifeStance Health (LFST) United States $2.904B 0.00
Addus HomeCare (ADUS) United States $1.974B 22.91
Astrana Health (ASTH) United States $1.946B 26.61
U.S Physical Therapy (USPH) United States $1.298B 34.13
Pennant (PNTG) United States $0.864B 34.93
Aveanna Healthcare Holdings (AVAH) United States $0.799B 0.00
Atai Life Sciences (ATAI) Germany $0.305B 0.00
Bioqual (BIOQ) United States $0.054B 0.00
Daxor (DXR) United States $0.036B 0.00
Ontrak (OTRK) United States $0.007B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.004B 0.00
IMAC Holdings (BACK) United States $0.001B 0.00
Psychemedics (PMD) United States $0.000B 0.00